心力衰竭患者的扩大血栓预防;未满足的需求
Majed S Al Yami1,2,3, Abdulmajeed M Alshehri4,5,6, Saeed M Alay4
1Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, P.O. Box 3660, Riyadh, 11481, Kingdom of Saudi Arabia. yamim@ksau-hs.edu.sa.
Heart failure reviews
|July 16, 2024
概括
心力衰竭患者可能从延长的血栓预防中受益,以预防静脉血栓塞栓症 (VTE). 识别高风险患者至关重要,因为目前的风险模型缺乏VTE预防的准确性和标准化.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
背景情况:
- 心力衰竭 (HF) 是导致心血管疾病和死亡的主要全球原因.
- 由于各种风险因素,HF患者患静脉血栓塞栓症 (VTE) 的风险增加.
- 目前的指导方针通常不建议在出院后进行延长型血栓预防,因为益处和出血风险不确定.
研究的目的:
- 审查VTE在HF患者中的发病率,病理生理学和预防.
- 评估在HF患者中延长血栓预防的证据.
- 突出需要改进VTE和高频出血风险评估模型的需要.
主要方法:
- 对HF患者VTE研究的文献综述.
- 对VTE预防的指导建议的分析.
- 对扩展性血栓预防的研究进行审查,包括对HF患者的亚组分析.
主要成果:
- 最近的证据表明,HF患者的延长血栓预防治疗没有增加出血风险.
- 现有的风险评估模型 (RAMs) 用于对HF患者的VTE预测具有可疑的准确性和缺乏标准化.
- 需要确定那些可以从延长性血栓预防中受益的HF患者.
结论:
- 在HF患者中优化VTE预防需要更好的风险分层.
- 开发一个理想的RAM对于确定扩展血栓预防的候选人至关重要.
- 保持静脉瘤风险和出血风险的平衡对于医疗病患者至关重要,包括那些患有高血压患者.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
668
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
668
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Diuretics
361
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
361
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


